Welcome to our dedicated page for McKesson Corporation news (Ticker: MCK), a resource for investors and traders seeking the latest updates and insights on McKesson Corporation stock.
McKesson Corporation (symbol: MCK) is a leading healthcare services and information technology company, dedicated to improving the business of healthcare globally. Ranked 11th on the Fortune 500 list, McKesson collaborates with a diverse range of stakeholders including payers, hospitals, physician offices, pharmacies, pharmaceutical companies, and other entities across the healthcare spectrum. The company's mission is to foster healthier organizations that deliver superior care to patients in every setting.
McKesson is one of the top three pharmaceutical wholesalers in the United States, engaging in the sourcing and distribution of branded, generic, and specialty pharmaceutical products. Their extensive client base includes retail chains, independent pharmacies, mail-order pharmacies, hospital networks, and healthcare providers. Alongside Cencora and Cardinal Health, McKesson commands over 90% of the US pharmaceutical wholesale industry.
Beyond the US, McKesson's reach extends to Canada, where they are involved in pharmaceutical wholesale and distribution. Additionally, McKesson supplies medical-surgical products and equipment to healthcare facilities and offers a range of technology solutions tailored for pharmacies.
McKesson's comprehensive service offerings include pharmaceutical and medical-surgical supply management, healthcare information technology solutions, and business and clinical services. The company is committed to helping its customers enhance their financial, operational, and clinical performance, ultimately aiming to deliver better patient care.
Recent achievements include strategic partnerships and innovative projects that continue to position McKesson as a key player in the healthcare industry. Their ongoing projects are designed to streamline operations and improve efficiency across the board, ensuring that healthcare providers can focus on patient care.
For more details on McKesson Corporation, visit www.mckesson.com.
The Board of Directors of McKesson Corporation (NYSE:MCK) has declared a regular dividend of 54 cents per share of common stock. This dividend will be payable on July 3, 2023, to stockholders recorded as of June 1, 2023. McKesson, a leader in healthcare services, focuses on improving health outcomes by partnering with various sectors including biopharma companies, care providers, and pharmacies. The company aims to enhance accessibility and affordability in healthcare, impacting numerous areas within the industry.
McKesson Corporation (NYSE: MCK) is set to release its fourth-quarter and full-year fiscal 2023 financial results after market close on Monday, May 8, 2023. A live webcast of the earnings conference call will be held at 4:30 PM Eastern Time to discuss the financial outcomes. Investors can access the webcast on McKesson’s Investor Relations website, where the earnings release and supporting materials will also be available. McKesson is a leader in healthcare services, dedicated to improving health outcomes and partnering with various stakeholders to enhance the accessibility and affordability of quality care.
FAQ
What is the current stock price of McKesson Corporation (MCK)?
What is the market cap of McKesson Corporation (MCK)?
What services does McKesson Corporation provide?
Where does McKesson Corporation operate?
Who are McKesson's primary clients?
What makes McKesson a leading pharmaceutical wholesaler?
How does McKesson help improve healthcare delivery?
What are some recent achievements of McKesson Corporation?
Can individuals buy products directly from McKesson?
How does McKesson contribute to the healthcare industry?
What is the significance of McKesson's partnerships?
Where can I find more information about McKesson Corporation?
